Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)
1.125
+0.005 (0.45%)
At close: Jul 28, 2026
BIT:ERFO Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.44 | 0.32 | 0.76 | 1.46 | 0.37 |
Cash & Short-Term Investments | 0.44 | 0.32 | 0.76 | 1.46 | 0.37 |
Cash Growth | 37.17% | -58.22% | -47.78% | 295.16% | -58.83% |
Accounts Receivable | 0.59 | 0.47 | 0.52 | 0.4 | 0.36 |
Other Receivables | 0.15 | 0.13 | 0.13 | 0.09 | 0.19 |
Total Trade Receivables | 0.74 | 0.6 | 0.64 | 0.49 | 0.55 |
Inventory | 1.17 | 0.99 | 0.98 | 0.94 | 0.65 |
Other Current Assets | 0.31 | 0.27 | 0.51 | 1.02 | 0.24 |
Total Current Assets | 2.65 | 2.18 | 2.9 | 3.91 | 1.81 |
Net Property, Plant & Equipment | 1.71 | 1.87 | 2.11 | 2.15 | 2.07 |
Other Intangible Assets | 2.28 | 2.69 | 2.56 | 2.81 | 2.39 |
Goodwill | 0 | 0 | 0 | 0 | 0 |
Long-Term Investments | 3.55 | 2.15 | 1.86 | 0.27 | 0.69 |
Other Long-Term Assets | 0.8 | 0.92 | 0.75 | 1.36 | 0.18 |
Total Assets | 10.99 | 9.81 | 10.17 | 10.5 | 7.13 |
Accounts Payable | 0.61 | 0.55 | 0.48 | 0.66 | 0.33 |
Accrued Expenses | 0.08 | 0.07 | 0.05 | 0.05 | 0.04 |
Short-Term Debt | 0.38 | 0.13 | 0.13 | 0.13 | 0.17 |
Other Current Liabilities | 0.51 | 0.7 | 0.87 | 1.07 | 1.12 |
Total Current Liabilities | 1.58 | 1.45 | 1.54 | 1.91 | 1.66 |
Long-Term Debt | 0.97 | 0.24 | 0.32 | 0.45 | 0.58 |
Other Long-Term Liabilities | 0.33 | 0.28 | 0.23 | 0.2 | 0.16 |
Total Long-Term Liabilities | 1.31 | 0.53 | 0.55 | 0.64 | 0.73 |
Total Liabilities | 2.89 | 1.98 | 2.09 | 2.55 | 2.39 |
Common Stock | 1.75 | 1.75 | 1.75 | 1.75 | 1.5 |
Treasury Stock | -0.54 | -0.56 | -0.44 | - | - |
Additional Paid-in Capital | 2.75 | 2.75 | 2.75 | 2.75 | - |
Accumulated Other Comprehensive Income | 1.96 | 1.96 | 1.96 | 1.96 | 1.96 |
Retained Earnings | 2.18 | 1.93 | 2.06 | 1.48 | 1.27 |
Shareholders' Equity | 8.1 | 7.83 | 8.08 | 7.94 | 4.74 |
Total Liabilities & Equity | 10.99 | 9.81 | 10.17 | 10.5 | 7.13 |
Total Debt | 1.35 | 0.38 | 0.45 | 0.58 | 0.74 |
Net Cash (Debt) | -0.91 | -0.06 | 0.31 | 0.88 | -0.37 |
Net Cash Growth | - | - | -64.88% | - | - |
Net Cash Per Share | -0.11 | -0.01 | 0.03 | 0.10 | -0.25 |
Book Value | 8.1 | 7.83 | 8.08 | 7.94 | 4.74 |
Book Value Per Share | 0.95 | 0.92 | 0.90 | 0.88 | 3.16 |
Tangible Book Value | 5.82 | 5.14 | 5.52 | 5.13 | 2.35 |
Tangible Book Value Per Share | 0.68 | 0.61 | 0.61 | 0.57 | 1.56 |